Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Biogen Inc. (BIIB) had Cash Flow from Financial Activities of $-43.80M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.48B |
|
$319.50M |
|
$661.00M |
|
$1.82B |
|
$2.08B |
|
$397.40M |
|
$-19.70M |
|
$377.70M |
|
$377.70M |
|
$319.50M |
|
$319.50M |
|
$319.50M |
|
$319.50M |
|
$397.40M |
|
$709.40M |
|
147.20M |
|
148.40M |
|
$2.17 |
|
$2.15 |
|
| Balance Sheet Financials | |
$9.19B |
|
$3.02B |
|
$20.29B |
|
$29.48B |
|
$3.00B |
|
$6.29B |
|
$7.83B |
|
$10.83B |
|
$18.65B |
|
$3.11B |
|
$18.65B |
|
147.60M |
|
| Cash Flow Statement Financials | |
$645.50M |
|
$-209.50M |
|
|
Cash Flow from Financial Activities |
$-43.80M |
$3.01B |
|
$3.38B |
|
$374.20M |
|
$84.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.06 |
|
-- |
|
-- |
|
0.25 |
|
0.34 |
|
73.32% |
|
16.04% |
|
16.04% |
|
-- |
|
15.24% |
|
12.89% |
|
$594.30M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.34 |
|
1.81 |
|
49.73 |
|
1.71% |
|
10.28% |
|
1.08% |
|
1.28% |
|
$126.37 |
|
$4.00 |
|
$4.35 |
|